BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 546792)

  • 1. Synergistic effect of polyriboinosinic acid:polyribocytidylic acid and either bacterial peptidoglycans or synthetic N-acetylmuramyl peptides on production of adjuvant-induced arthritis in rats.
    Kohashi O; Kotani S; Shiba T; Ozawa A
    Infect Immun; 1979 Nov; 26(2):690-7. PubMed ID: 546792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvant activities in production of reaginic antibody by bacterial cell wall peptidoglycan or synthetic N-acetylmuramyl dipeptides in mice.
    Ohkuni H; Norose Y; Ohta M; Hayama M; Kimura Y; Tsujimoto M; Kotani S; Shiba T; Kusumoto S; Yokogawa K; Kawata S
    Infect Immun; 1979 May; 24(2):313-8. PubMed ID: 457277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arthritis-inducing ability of a synthetic adjuvant, N-acetylmuramyl peptides, and bacterial disaccharide peptides related to different oil vehicles and their composition.
    Kohashi O; Tanaka A; Kotani S; Shiba T; Kusumoto S; Yokogawa K; Kawata S; Ozawa A
    Infect Immun; 1980 Jul; 29(1):70-5. PubMed ID: 7399708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant polyarthritis. V. Induction by N-acetylmuramyl-L-alanyl-D-isoglutamine, the smallest peptide subunit of bacterial peptidoglycan.
    Chang YH; Pearson CM; Chedid L
    J Exp Med; 1981 Apr; 153(4):1021-6. PubMed ID: 6972989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New model of a synthetic adjuvant, N-acetylmuramyl-L-alanyl-D-isoglutamine- induced arthritis: clinical and histologic studies in athymic nude and euthymic rats.
    Kohashi O; Aihara K; Ozawa A; Kotani S; Azuma I
    Lab Invest; 1982 Jul; 47(1):27-36. PubMed ID: 7087395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficient induction of collagen arthritis by the use of a synthetic muramyl dipeptide.
    Koga T; Sakamoto S; Onoue K; Kotani S; Sumiyoshi A
    Arthritis Rheum; 1980 Sep; 23(9):993-7. PubMed ID: 7417362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant activity of synthetic N-acetylmuramyl peptides in rats.
    Tanaka A; Saito R; Sugiyama K; Morisaki I; Kotani S
    Infect Immun; 1977 Jan; 15(1):332-4. PubMed ID: 832904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant activity of carbohydrate analogs of N-acetylmuramyl-L-alanyl-D-isoglutamine on the induction of delayed-type hypersensitivity to azobenzenearsonate-N-acetyl-L-tyrosine in guinea pigs.
    Azuma I; Okumura H; Saiki I; Kiso M; Hasegawa A; Tanio Y; Yamamura Y
    Infect Immun; 1981 Sep; 33(3):834-9. PubMed ID: 7287186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute and chronic polyarthritis induced by an aqueous form of 6-O-acyl and N-acyl derivatives of N-acetylmuramyl-L-alanyl-D-isoglutamine in euthymic rats and athymic nude rats.
    Kohashi O; Kohashi Y; Shigematsu N; Ozawa A; Kotani S
    Lab Invest; 1986 Sep; 55(3):337-46. PubMed ID: 3489128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arthritogenicity of wax D from various mycobacteria related to oil vehicle composition and to the combination with poly I:C, cord factor and acetylated wax D.
    Kohasi O; Pearson CM; Koga T
    Int Arch Allergy Appl Immunol; 1977; 53(4):357-65. PubMed ID: 852904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of thymus for N-acetyl muramyl-L-alanyl-D-isoglutamine-induced polyarthritis and granuloma formation in euthymic and athymic nude rats or in neonatally thymectomized rats.
    Kohashi O; Pearson CM; Tamaoki N; Tanaka A; Shimamura K; Ozawa A; Kotani S; Saito M; Hioki K
    Infect Immun; 1981 Feb; 31(2):758-66. PubMed ID: 7012019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of replacement of L-alanine residue by glycine, L-serine or D-alanine in an N-acetylmuramyl-L-alanyl-D-isoglutamine on immunoadjuvancies of molecules.
    Kotani S; Watanabe Y; Kinoshita F; Morisaki I; Kato K
    Biken J; 1977 Jun; 20(2):39-45. PubMed ID: 588232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Adjuvant activity and adjuvant arthritis].
    Tanaka A
    Kekkaku; 1980 Oct; 55(10):465-7. PubMed ID: 7230587
    [No Abstract]   [Full Text] [Related]  

  • 14. Oral immunoadjuvant activity of lipophilic derivatives of N-acetylglucosaminyl-beta(1-->4)-N-acetylmuramyl-L-alanyl-D-isoglutamin yl-(L)- 2,6-meso-diaminopimeric acid-(D)-amide.
    Ogawa T; Shimauchi H; Furuta R; Kawata S; Yokogawa K; Kotani S
    Vaccine; 1995 Jul; 13(10):887-9. PubMed ID: 7483759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative study of the effects of peptidoglycan monomer and structurally related adamantyltripeptides on humoral immune response to ovalbumin in the mouse.
    Tomasić J; Hanzl-Dujmović I; Spoljar B; Vranesić B; Santak M; Jovicić A
    Vaccine; 2000 Jan; 18(13):1236-43. PubMed ID: 10649625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of certain biological activities of muramyl dipeptide derivatives after conjugation to a multi-poly(DL-alanine)--poly(L-lysine) carrier.
    Chedid L; Parant M; Parant F; Audibert F; Lefrancier F; Choay J; Sela M
    Proc Natl Acad Sci U S A; 1979 Dec; 76(12):6557-61. PubMed ID: 293743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A comparative study of the immunological properties of peptidoglycans of different origins].
    Zakharova NS; Shepeleva IB; Kalina NG; Britsina MV; Elkina SI; Andronova TM; Ermolova EV
    Zh Mikrobiol Epidemiol Immunobiol; 1991 Jan; (1):52-5. PubMed ID: 1858472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant activities of quinonyl-N-acetyl muramyl dipeptides in mice and guinea pigs.
    Saiki I; Tanio Y; Yamawaki M; Uemiya M; Kobayashi S; Fukuda T; Yukimasa H; Yamamura Y; Azuma I
    Infect Immun; 1981 Jan; 31(1):114-21. PubMed ID: 6971259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitogenic effects of bacterial cell walls, their fragments, and related synthetic compounds on thymocytes and splenocytes of guinea pigs.
    Takada H; Tsujimoto M; Kotani S; Kusumoto S; Inage M; Shiba T; Nagao S; Yano I; Kawata S; Yokogawa K
    Infect Immun; 1979 Aug; 25(2):645-52. PubMed ID: 314932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficient genetically controlled formation of antibody to a synthetic antigen [poly(LTyr, LGlu)-poly(DLAla)- -poly(LLys)] covalently bound to a synthetic adjuvant (N-acetylmuramyl-L-alanyl-D-isoglutamine).
    Mozes E; Sela M; Chedid L
    Proc Natl Acad Sci U S A; 1980 Aug; 77(8):4933-7. PubMed ID: 6776530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.